e-learning
resources
Vienna 2009
Monday, 14.09.2009
Diagnosis of pleural effusions and rare tumours experience
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Malignant pleural effusions (MPE) – comparative yield of cytological and histopathological methods
M. Fijalkowski, A. Rul (Lodz, Poland)
Source:
Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Session:
Diagnosis of pleural effusions and rare tumours experience
Session type:
E-Communication Session
Number:
1931
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Fijalkowski, A. Rul (Lodz, Poland). Malignant pleural effusions (MPE) – comparative yield of cytological and histopathological methods. Eur Respir J 2009; 34: Suppl. 53, 1931
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Diagnostic yield of pleural fluid cytology in malignant effusions – Is timing of collection important?
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010
The impact of malignant pleural effusion – A retrospective review
Source: Annual Congress 2011 - Pleural and mediastinal malignancies: management and rare clinical cases
Year: 2011
Critical issues in pleural fluid examinations: laboratory parameters, tumour markers and cytological methods
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=110
Year: 2002
Diagnosis of malignant pleural effusions; cytology or biopsy?
Source: Eur Respir J 2004; 24: Suppl. 48, 72s
Year: 2004
Eosinophilic pleural effusions – Is everything clear?
Source: Annual Congress 2012 - Medical access to the pleura
Year: 2012
Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010
Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 775s
Year: 2006
Value of the video assisted thoracoscopy in the diagnosis of the pleural effusions – Our experience
Source: Annual Congress 2011 - Pleural diseases and pneumothorax
Year: 2011
Malignant pleural effusions: diagnosis and management
Source: International Congress 2017 – PG5 Pleural disease management
Year: 2017
Malignant pleural effusions: from the diagnosis to the management
Source: International Congress 2015 – ME2 Malignant pleural effusions: from diagnosis to management
Year: 2015
Ultrasound guided pleural brushing: A new method for obtaining pleural specimen in malignant effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016
Usefulness of cytology and blind needle pleural biopsy (BNPB) histopathology findings in malignant pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 50s
Year: 2006
Malignant pleural effusion - diagnosis and treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 272s
Year: 2002
Metastatic pleural effusions (mpes)
Source: Annual Congress 2008 - Various aspects of thoracic oncology
Year: 2008
Cytology and DNA ploidy techniques in the diagnosis of malignant pleural effusion
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012
Evaluation of pleural fluid human epididymis 4 (HE4) as a marker of malignant pleural effusions
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012
Diagnostic yield of the new pleural biopsy needle ((Esmat’s needle)) in exudative pleural effusion
Source: International Congress 2016 – Pleural diseases
Year: 2016
Pathological diagnosis of malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020
Diagnostic pleuroscopy and pleuroscopic talc pleurodesis in malignant pleural effusions – a study on efficacy and safety
Source: Annual Congress 2009 - Pleural and mediastinal diseases
Year: 2009
Comparative evaluation of CA-125, CA 19-9, CA 15-3 and CEA in exudative benign and malignant pleural effusion
Source: Annual Congress 2010 - Novel approach in diagnosis and treatment of pleural effusions
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept